Skip to main content

NuTec to Open UK-based Office to Tap European Market

NEW YORK, March 15 – Software developer NuTec Sciences announced plans Thursday to make a push into the European life sciences market.

The company said its new office, NuTec Sciences Limited, would be located near Manchester, UK, and named Stephane Labonte managing director in charge of growing NuTec’s life science business and its energy services division in Europe.

“The expansion of operations into Europe reflects the success of our US business model,” Michael Mott, vice president of marketing for NuTec. “By leveraging our core competencies in informatics, integrated software, and massively parallel supercomputing technology, we are creating highly specialized products for the marketplace.”

The company, which hopes to form alliances with British labs and universities, is also planning to install a massively parallel supercomputer in Europe starting sometime within the next year.

In December NuTec said it had contracted IBM to build a 7.5-teraflop computing cluster that NuTec’s life science unit in Atlanta would use to study genes’ role in disease.

NuTec develops desktop software applications and massively parallel supercomputing technology.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.